BRIEF published on 10/30/2025 at 14:51, 1 year ago The Vanguard Group Reports Stake in NCC Group plc Form 8.3 The Vanguard Group Shareholding Cyber Security NCC Group
BRIEF published on 10/30/2025 at 14:50, 1 year ago The Vanguard Group Discloses Interests in Mural Oncology Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Mural Oncology
BRIEF published on 10/30/2025 at 14:48, 1 year ago Vanguard's Stake in JTC plc Disclosed in Recent Filing Form 8.3 Takeover Code Vanguard Group Equity Position JTC Plc
BRIEF published on 10/30/2025 at 14:47, 1 year ago The Vanguard Group Reports Position in Just Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group Plc
PRESS RELEASE published on 10/30/2025 at 14:46, 1 year ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.90% interest in NCC Group plc as of 29-Oct-2025. Details in Form 8.3 public disclosure The Vanguard Group, Inc. Form 8.3 Stock Market Interest Disclosure NCC Group Plc
BRIEF published on 10/30/2025 at 14:45, 1 year ago Vanguard Discloses Interest in Spire Healthcare Form 8.3 Takeover Code Vanguard Group Spire Healthcare Stock Disclosure
PRESS RELEASE published on 10/30/2025 at 14:45, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc. Form 8.3 filed with the Irish Takeover Panel on 30-Oct-2025 Form 8.3 Irish Takeover Panel Vanguard Group Interest Disclosure Mural Oncology Plc
BRIEF published on 10/30/2025 at 14:44, 1 year ago The Vanguard Group Discloses Stake in Big Yellow Group plc Ordinary Shares The Vanguard Group Takeover Code Stake Disclosure Big Yellow Group
PRESS RELEASE published on 10/30/2025 at 14:43, 1 year ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% interest in JTC plc's 1p ordinary shares. Dealing and disclosure details provided as per Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code Vanguard Group 1p Ordinary Shares JTC Plc
BRIEF published on 10/30/2025 at 14:43, 1 year ago The Vanguard Group Discloses Position in Alpha Group International plc Ordinary Shares Takeover Code Securities Disclosure Vanguard Group Alpha Group
Published on 11/10/2026 at 14:45, 3 hours 41 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 3 hours 55 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 3 hours 56 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 3 hours 56 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 4 hours 26 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 18:10, 15 minutes ago INTRODUCING ATMA: A REVOLUTION IN WELLBEING BY AMAN GROUP
Published on 11/10/2026 at 18:02, 24 minutes ago Symrise AG announces Chief Financial Officer transition and extension of Walter Ribeiro’s Executive Board appointment
Published on 11/10/2026 at 18:00, 26 minutes ago 2CRSi SA: UET and 2CRSi Partner to Bring Validated, Warranty-Backed, Immersion-Cooled AI Compute to the Edge
Published on 11/10/2026 at 17:45, 41 minutes ago EQS-Adhoc: Airbus reports share buybacks for week starting 2 November 2026
Published on 11/10/2026 at 17:31, 54 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 4 hours 25 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 7 hours 23 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 11 hours 26 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 23 hours 56 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
